Function of NKT cells, potential anti-HIV effector cells, are improved by beginning HAART during acute HIV-1 infection

International Immunology

Volumn 19, Issue 8, 2007, Pages 943-951

  Vasan, Sandhya ^a   Poles, Michael A ^a,b   Horowitz, Amir ^a,b   Siladji, Esther E ^a   Markowitz, Martin ^a   Tsuji, Moriya ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acute infection; HAART; HIV; NKT

Indexed keywords

ANTIRETROVIRUS AGENT; CD161 ANTIGEN; CD4 ANTIGEN; GAMMA INTERFERON;

ACUTE DISEASE; ADULT; ANTIVIRAL ACTIVITY; ARTICLE; CD4 LYMPHOCYTE COUNT; CD4 LYMPHOCYTE PERCENTAGE; CELLULAR IMMUNITY; CONTROLLED STUDY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INNATE IMMUNITY; LYMPHOCYTE FUNCTION; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER T CELL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

ADULT; ANTIGENS, SURFACE; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; IMMUNITY, NATURAL; INTERFERON TYPE II; KILLER CELLS, NATURAL; LECTINS, C-TYPE; MALE; MIDDLE AGED; T-LYMPHOCYTE SUBSETS;

EID: 34548591355     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxm055     Document Type: Article

References (49)

1. Koseki, H., Asano, H., Inaba, T. et al. 1991. Dominant expression of a distinctive V14+ T-cell antigen receptor alpha chain in mice. Proc. Natl Acad. Sci. USA 88:7518.
2. Exley, M., Garcia, J., Balk, S. P. and Porcelli, S. 1997. Requirements for CD1d recognition by human invariant Valpha24+ CD4-CD8- T cells. J. Exp. Med. 186:109.
3. Godfrey, D. I., Hammond, K. J., Poulton, L. D., Smyth, M. J. and Baxter, A. G. 2000. NKT Cells: Facts, functions and fallacies. Immunol. Today 11:573.
4. Chen, H. and Paul, W. E. 1997. Cultured NK1.1+ CD4+ T cells produce large amounts of IL-4 and IFN-gamma upon activation by anti-CD3 or CD1. J. Immunol. 159:2240.
5. Nieda, M., Okai, M., Tazbirkova, A. et al. 2004. Therapeutic activation of Valpha24+Vbeta11+ NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity. Blood 103:383.
6. Tomura, M., Yu, W. G., Ahn, H. J. et al. 1999. A novel function of Valpha14+CD4+NKT cells: Stimulation of IL-12 production by antigen-presenting cells in the innate immune system. J. Immunol. 163:93.
7. Kitamura, H., Iwakabe, K., Yahata, T. et al. 1999. The natural killer T (NKT) cell ligand alpha-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells. J. Exp. Med. 189:1121.
8. Schmeig, J., Yang, G., Franck, R. W., Van Rooijen, N. and Tsuji, M. 2005. Glycolipid presentation to natural killer T cells differs in an organ-dependent fashion. Proc. Natl Acad. Sci. USA 102:1127.
9. Hashimoto, W., Takeda, K., Anzai, R. et al. 1995. Cytotoxic NK1.1 Ag+ alpha beta T cells with intermediate TCR induced in the liver of mice by IL-12. J. Immunol. 154:4333.
10. Kawano, T., Cui, J., Koezuka, Y. et al. 1998. Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Valpha14 NKT cells. Proc. Natl Acad. Sci. USA 10:5690.
11. Nakui, M., Iwakabe, K., Ohta, A. et al. 1999. Natural killer T cell ligand alpha-galactosylceramide inhibited lymph node metastasis of highly metastatic melanoma cells. Jpn. J. Cancer Res. 90:801.
12. Nicol, A., Nieda, M., Koezuka, Y. et al. 2000. Human invariant valpha24+ natural killer Tcells activated by alpha-galactosylceramide (KRN7000) have cytotoxic anti-tumor activity through mechanisms distinct from T cells and natural killer cells. Immunology 99:229.
13. Illes, Z., Kondo, T., Newcombe, J., Oka, N., Tabira, T. and Yamamura, T. 2000. Differential expression of NK T cell V alpha 24J alpha Q invariant TCR chain in the lesions of multiple sclerosis and chronic inflammatory demyelinating polyneuropathy. J. Immunol. 164:4375.
14. Hammond, K. J., Poulton, L. D., Palmisano, L. J., Silveira, P. A., Godfrey, D. I. and Baxter, A. G. 1998. alpha/beta-T cell receptor (TCR)+CD4-CD8- (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of (IL)-4 and/or IL-10. J. Exp. Med. 187:1047.
15. Gonzalez-Aseguinolaza, G., de Oliveira, C., Tomaska, M. et al. 2000. Alpha -galactosylceramide-activated Valpha 14 natural killer T cells mediate protection against murine malaria. Proc. Natl Acad. Sci. USA 97:8461.
16. Van Dommelen, S. L.H., Tabarias, H. A., Smyth, M. J. and Degli-Esposti, M. A. 2003. Activation of natural killer (NK) T cells during murine cytomegalovirus infection enhances the antiviral response mediated by NK cells. J. Virol. 77:1877.
17. Kinjo, Y., Wu, D., Kim, G. et al. 2005. Recognition of bacterial glycosphingolipids by natural killer T cells. Nature 434:520.
18. Mattner, J., Debord, K. L., Ismail, N. et al. 2005. Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 434:525.
19. Kawakami, K., Kinjo, Y., Uezu, K. et al. 2001. Monocyte chemoattractant protein-1-dependent increase of V alpha 14 NKTcells in lungs and their roles in Th1 response and host defense in cryptococcal infection. J. Immunol. 167:6525.
20. Blackstock, R. and Murphy, J. W. 2004. Age-related resistance of C57BL/6 mice to Cryptococcus neoformans is dependent on maturation of NKT cells. Infect. Immun. 72:5175.
21. Van der Vliet, H. J., von Blomberg, B. M., Hazenberg, M. D. et al. 2002. Selective decrease in circulating V alpha 24+V beta 11+ NKT cells during HIV type 1 infection. J. Immunol. 168:1490.
22. Oxenius, A., Price, D. A., Easterbrook, P. J. et al. 2000. Early highly active antiretroviral therapy for acute HIV-1 infection preserves immune function of CD8+ and CD4+ T lymphocytes. Proc. Natl Acad. Sci. USA 97:3382.
23. Kaufmann, G. R., Zaunders, J. J., Cunningham, P. et al. 2000. Rapid restoration of CD4 T cell subsets in subjects receiving antiretroviral therapy during primary HIV-1 infection. AIDS 14:2643.
24. Fleuridor, R., Wilson, B., Hou, R., Landay, A., Kessler, H. and Al-Harthi, L. 2003. CD1d-restricted natural killer T cells are potent targets for human immunodeficiency virus infection. Immunology 108:3.
25. Sandberg, J. K., Fast, N. M., Palacios, E. H. et al. 2002. Selective loss of innate CD4(+) V alpha 24 natural killer T cells in human immunodeficiency virus infection. J. Virol. 76:7528.
26. Motsinger, A., Azimzadeh, A., Stanic, A. K. et al. 2003. Identification and simian immunodeficiency virus infection of CD1d-restricted macaque natural killer T cells. J. Virol. 77:8153.
27. Moll, M., Snyder-Cappione, J., Spotts, G., Hecht, F. M., Sandberg, J. K. and Nixon, D. F. 2006. Expansion of CD1d-restricted NKT cells in patients with primary HIV-1 infection treated with interleukin-2. Blood 107:3081.
28. Kottilil, S., Chun, T. W., Moir, S. et al. 2003. Innate immunity in human immunodeficiency virus infection: Effect of viremia on natural killer cell function. J. Infect. Dis. 187:1038.
29. Bonaparte, M. I. and Barker, E. 2003. Inability of natural killer cells to destroy autologous HIV-infected T lymphocytes. AIDS 17:487.
30. Weber, K., Meyer, D., Grosse, V., Stoll, M., Schmidt, R. E. and Heiken, H. 2000. Reconstitution of NK cell activity in HIV-1 infected individuals receiving antiretroviral therapy. Immunobiology 202:172.
31. Parato, K. G., Kumar, A., Badley, A. D. et al. 2002. Normalization of natural killer cell function and phenotype with effective anti-HIV therapy and the role of IL-10. AIDS 16:1251.
32. Azzoni, L., Papasavvas, E., Chehimi, J. et al. 2002. Sustained impairment of IFN-gamma secretion in suppressed HIV-infected patients despite mature NK cell recovery: Evidence for a defective reconstitution of innate immunity. J. Immunol. 168:5764.
33. Fogli, M., Costa, P., Murdaca, G. et al. 2004. Significant NK cell activation associated with decreased cytolytic function in peripheral blood of HIV-1-infected patients. Eur. J. Immunol. 34:2313.
34. Martini, F., Urso, R., Gioia, C. et al. 2000. Gammadelta T-cell anergy in human immunodeficiency virus-infected persons with opportunistic infections and recovery after highly active antiretroviral therapy. Immunology 100:481.
35. Martini, F., Poccia, F., Goletti, D. et al. 2002. Acute human immunodeficiency virus replication causes a rapid and persistent impairment of Vgamma9Vdelta2 T cells in chronically infected patients undergoing structured treatment interruption. J. Infect. Dis. 186:847.
36. Poles, M. A., Barsoum, S., Yu, W. et al. 2003. Human immunodeficiency virus type 1 induces persistent changes in mucosal and blood gammadelta T cells despite suppressive therapy. J. Virol. 77:10456.
37. Ute-Christiane, M., Owen, R. E., Taylor, E. et al. 2005. Shared alternations in NK cell frequency, phenotype, and function in chronic human immunodeficiency virus and hepatitis C virus infections. J. Virol. 79:12365.
38. Gumperz, J. E., Miyake, S., Yamamura, T. and Brenner, M. B. 2002. Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining. J. Exp. Med. 195:625.
39. Brigl, M., van den Elzen, P., Chen, X. et al. 2006. Conserved and heterogeneous lipid antigen specificities of CD1d-restricted NKT cell receptors. J. Immunol. 176:3625.
40. Sandberg, J. K., Bhardwaj, N. and Nixon, D. F. 2003. Dominant effector memory characteristics, capacity for dynamic adaptive expansion, and sex bias in the innate Valpha24 NKT cell compartment. Eur. J. Immunol. 33:588.
41. Motsinger, A., Haas, D. W., Stanic, A. K., Van Kaer, L., Joyce, S. and Unutmaz, D. 2002. CD1d-restricted human natural killer T cells are highly susceptible to human immunodeficiency virus 1 infection. J. Exp. Med. 195:869.
42. Hage, C. A., Kohli, L. L., Cho, S., Brutkiewicz, R. R., Twigg, H. L. III and Knox, K. S. 2005. Human immunodeficiency virus gp120 downregulates CD1d cell surface expression. Immunol. Lett. 98:131.
43. Carnaud, C., Lee, D., Donnars, O. et al. 1999. Cutting edge: cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. J. Immunol. 163:4647.
44. Gumperz, J. E., Roy, C., Makowska, A. et al. 2000. Murine CD1d-restricted T cell recognition of cellular lipids. Immunity 12:211.
45. Unutmaz, D. 2003. NKT cells and HIV infection. Microbes Infect. 5:1041.
46. DelaRosa, O., Tarazona, R., Casado, J. G. et al. 2002. Valpha24+ NKTcells are decreased in elderly humans. Exp. Gerontol. 37:213.
47. Crough, T., Purdie, D. M., Okai, M., Maksoud, A., Nieda, M. and Nichol, A. J. 2004. Modulation of human Valpha24(+)Vbeta11(+) NKT cells by age, malignancy and conventional anticancer therapies. Br. J. Cancer. 91:1880.
48. Molling, J. W., Kolgen, W., van der Vliet, H. J. et al. 2005. Peripheral blood IFN-gamma-secreting Valpha24+Vbeta11+ NKT cell numbers are decreased in cancer patients independent of tumor type or tumor load. Int. J. Cancer 116:87.
49. Faunce, D., Palmer, J. L., Paskowicz, K. K., Witte, P. L. and Kovacs, E. J. 2005. CD1d-restricted NKT cells contribute to the age-associated decline of t cell immunity. J. Immunol. 175:3102.